In: Experimental Brain Research, 2015, vol. 233, no. 5, p. 1365-1375
|
In: Social Cognitive and Affective Neuroscience, 2016, vol. 11, no. 6, p. 1017-1025
|
In: European Archives of Psychiatry and Clinical Neuroscience, 2015, vol. 265, no. 8, p. 637-645
|
In: Journal of Gambling Studies, 2015, vol. 31, no. 1, p. 295-297
|
In: International Journal of Neuropsychopharmacology, 2016, vol. 19, no. 7, p. -
|
In: International Journal of Neuropsychopharmacology, 2016, vol. 19, no. 11, p. -
|
In: Social Cognitive and Affective Neuroscience, 2018, vol. 13, no. 10, p. 1071-1080
|
In: Physical Chemistry Chemical Physics, 2015, vol. 17, no. 24, p. 15589–15597
Alpha-synuclein (AS) is a synaptic protein that is directly involved in Parkinson's disease due to its tendency to form protein aggregates. Since AS aggregation can be dependent on the interactions between the protein and the cell plasma membrane, elucidating the membrane binding properties of AS is of crucial importance to establish the molecular basis of AS aggregation into toxic fibrils....
|
In: European Neuropsychopharmacology, 2020, vol. 37, p. 70–81
Recent studies have shown that Lethal-7 (let-7) microRNA (miRNA) is involved in a wide range of psychiatric disorders such as anxiety, depression, schizophrenia, and cocaine addiction. However, the exact role of let-7d miRNA in regulating ethanol intake and preference remains to be elucidated. The aim of the present study was to clarify the role of accumbal let-7d in controlling...
|
In: Cell Systems, 2019, vol. 9, no. 3, p. 309-320.e8
Proteinaceous inclusions containing alpha-synuclein (α-Syn) have been implicated in neuronal toxicity in Parkinson’s disease, but the pathways that modulate toxicity remain enigmatic. Here, we used a targeted proteomic assay to simultaneously measure 269 pathway activation markers and proteins deregulated by α-Syn expression across a panel of 33 Saccharomyces cerevisiae strains that...
|